Close this search box.

Peter Huskinson

Peter Huskinson


Peter is an established senior leader with international experience transforming public and private sector services for customers. He has a strong track record in health policy, commissioning, health economics, pharmaceutical industry relations, and leadership practice in regional and national health leadership roles in NHS England and Te Whatu Ora.

As NHS England’s first commercial director, Peter secured access to a pipeline of cost-effective new medicines for cancer and rare diseases, negotiated the UK government’s pharmaceutical industry agreement, and led the award-winning programme to eliminate Hepatitis C.

He enables innovative change through effective partnerships with clinicians, equity leaders and consumer advocates, driving the adoption of evidence-based care for better value affordable health gain.

Peter’s wide-ranging experience spans public health, tertiary and complex care, elective care and diagnostics, cancer services, long term conditions, mental health, primary care, community services, Māori and Pacific health, and child development.

His passion is reorienting health systems towards prevention, early intervention, and equity – realigning incentives, processes, and funding flows for clinically led change.

Peter has specific expertise in the following areas:

  • Health system performance benchmarking and baseline investment review
  • Collaborative governance and operating model design
  • Value based purchasing and Pay-for-Performance incentives
  • Cost effectiveness analysis and investment prioritisation
  • Service review, evaluation, and commissioning for change
  • Strategic planning, Demand, Capacity and Waitlist management
  • Commercial strategy, procurement, contracting and provider development.



  • Economic and market analysis
  • Evaluations
  • Financial modelling
  • Regulatory and cost benefit analysis
  • Strategy and business cases


  • Health and wellbeing
  • Iwi and Māori
  • Public sector policy and finance

Qualifications & accolades

  • MSc with distinction, Health Economics Policy & Management, London School of Economics and Political Science, (UK)
  • BSc (Hons) first class, Business Administration, University of Bath (UK)
  • Best External Collaboration at the World Procurement Awards for the groundbreaking industry partnership to eliminate hepatitis C.

Recent work highlights include:

  • A baseline review of New Zealand’s Hospital and specialist services expenditure to bring insight into current patterns of spending, drivers of cost, equity of outcome, and the opportunities for efficiency across over $13 billion annual expenditure at national, regional and district levels, and forecasting demand, supply, and cost of care to 2040
  • Global evidence review of best practice and innovation in healthcare payment systems. The literature review assessed international models of health system practice and provided an opportunity assessment based on applicability to the New Zealand context
  • Design and development of future allocation purchasing and payment systems for hospital and specialist services. The objective was to provide Health New Zealand with options for purchasing models, the use of value-based purchasing, and frameworks for reimbursing publicly funded hospital and specialist care. The work secured board support for a multi-year programme of change and Sapere was commissioned to provide technical impact assessment and assurance for the first year of implementation
  • Current investment review of New Zealand Cancer services, linking registry and service data and forecasting demand, supply, and cost of care to 2040
  • Development of an evidence-based methodology for place-based resource assessment, which quantified policy choices for addressing differences in avoidable mortality and unmet need to inform decisions about funding
  • A review of the public health accountabilities framework for three national bodies following implementation of health reforms to enable clarity in responsibilities and improved collaborative action and governance
  • Keynote Speaker on the future of activity-based funding for Queensland Health, examining global trends, opportunities, and insights from experience of delivery of reforms to improve quality and equity.